西妥昔单抗联合放射和化学疗法治疗晚期鼻咽癌患者的观察与护理

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Tham I, Lu J. Controversies and challenges in the current management of nasopharyngeal cancer[J]. Expert Rev Anticancer Ther, 2010, 10(9): 1439-1450.
[2]	Le Tourneau C, Siu L. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck[J]. Curr Opin Oncol, 2008, 20(3): 256-263.
[3]	吕汪霞,马胜林. 西妥昔单抗的临床研究新进展[J]. 医学综述, 2010, 16(9): 1345-1348.
[4]	Pryor D, Porceddu S, Burmeister B, et al. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer[J]. Radiother Oncol, 90(2): 172-176.
[5]	Baselga J. The EGFR as a targe for anti-cancer therapy focus on cetuximab[J]. Eur J Cancer, 2001, 37(Suppl 4): 16-22.
[6]	David E. Cetuximab in metastatic colorectal cancer[J]. London Cancer New Drugs Grorp-APC/DTC Briefing, 2005, 7(1): 1-10.

Full-Text